Hainan Shuangcheng Pharmaceuticals Co Ltd (002693):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Hainan Shuangcheng Pharmaceuticals Co Ltd (002693) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9422
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hainan Shuangcheng Pharmaceuticals Co Ltd (Shuangcheng Pharma) is a pharmaceutical company that develops, manufactures and markets generic peptide drugs, finished dosages and active pharmaceutical ingredients. Its products include thymalfasin, thymopetin, somatostatin, levocarnitine, famotidine, ligustrazine phosphate, adenosine cyclophosphate, sodium ferulate, ganciclovir, pantoprazole sodium, omeprazole sodium, calcium folinate, inosine, aciclovir, clindamycin hydrochloride and azithromycin, among others. Shuangcheng Pharma sells its products throughout China. The company operates its manufacturing facility in Haikou, China. Shuangcheng Pharma is headquartered in Haikou, China.

Hainan Shuangcheng Pharmaceuticals Co Ltd (002693) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hainan Shuangcheng Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Hainan Shuangcheng Acquires Selling Right of Tauro-ursodesoxycholic Acid 11
Equity Offering 12
Hainan Shuangcheng Pharma Withdraws Private Placement of shares for USD146 Million 12
Hainan Shuangcheng Pharma Completes IPO For US$95 Million 13
Acquisition 14
Hainan Shuangcheng Pharma Sells 46% Stake in Hangzhou-Based Biotechnology Company for USD39.5 Million 14
Hainan Shuangcheng Pharma to Acquire 74.9% Stake in Lyomark Pharma and Bendalis for up to USD33 Million 15
Hainan Shuangcheng Pharma to Acquire 56% Stake in Hangzhou Ausia BioTech for USD154 Million 16
Hainan Shuangcheng Pharmaceuticals Co Ltd – Key Competitors 17
Hainan Shuangcheng Pharmaceuticals Co Ltd – Key Employees 18
Hainan Shuangcheng Pharmaceuticals Co Ltd – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hainan Shuangcheng Pharmaceuticals Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Hainan Shuangcheng Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hainan Shuangcheng Acquires Selling Right of Tauro-ursodesoxycholic Acid 11
Hainan Shuangcheng Pharma Withdraws Private Placement of shares for USD146 Million 12
Hainan Shuangcheng Pharma Completes IPO For US$95 Million 13
Hainan Shuangcheng Pharma Sells 46% Stake in Hangzhou-Based Biotechnology Company for USD39.5 Million 14
Hainan Shuangcheng Pharma to Acquire 74.9% Stake in Lyomark Pharma and Bendalis for up to USD33 Million 15
Hainan Shuangcheng Pharma to Acquire 56% Stake in Hangzhou Ausia BioTech for USD154 Million 16
Hainan Shuangcheng Pharmaceuticals Co Ltd, Key Competitors 17
Hainan Shuangcheng Pharmaceuticals Co Ltd, Key Employees 18

List of Figures
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hainan Shuangcheng Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Hainan Shuangcheng Pharmaceuticals Co Ltd (002693):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Encompass Digital Media, Inc.:企業の戦略・SWOT・財務情報
    Encompass Digital Media, Inc. - Strategy, SWOT and Corporate Finance Report Summary Encompass Digital Media, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • NHPC Ltd (NHPC):電力:M&Aディール及び事業提携情報
    Summary NHPC Ltd (NHPC), a Government of India Enterprise, is an energy utility. It plans, promotes and organizes the development of hydro power plants. The company generates electricity using hydro, wind and solar sources. NHPC’s offerings cover the development operations of conventional and non-co …
  • CEZ, AS:発電所・企業SWOT分析
    CEZ, AS - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives …
  • SoftwareONE Holding AG (SWON):企業の財務・戦略的SWOT分析
    SoftwareONE Holding AG (SWON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • US Foods Holding Corp (USFD):企業の財務・戦略的SWOT分析
    US Foods Holding Corp (USFD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Polyphor AG (POLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Polyphor AG (Polyphor) is a clinical stage biopharmaceutical company that discovers and develops antibiotics and other specialty pharma products for severe or life-threatening diseases. The company offers hematopoietic stem cells for multiple myeloma patients, Pseudomonas infections and prot …
  • Westinghouse Air Brake Technologies Corporation:企業のM&A・事業提携・投資動向
    Westinghouse Air Brake Technologies Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Westinghouse Air Brake Technologies Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descript …
  • Thirumalai Chemicals Limited (TIRUMALCHM):企業の財務・戦略的SWOT分析
    Thirumalai Chemicals Limited (TIRUMALCHM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Oral Health Products, Inc.:企業の戦略・SWOT・財務情報
    Oral Health Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oral Health Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Individual Restaurant Company Limited:企業の戦略・SWOT・財務分析
    Individual Restaurant Company Limited - Strategy, SWOT and Corporate Finance Report Summary Individual Restaurant Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • GenomeDx Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary GenomeDx Biosciences Inc (GenomeDx) is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. The company offers decipher prostate cancer classifier, a transformative genomic test that provides an assessment of tumor agg …
  • Power Engineering Consulting 1 Joint Stock Company (TV1):企業の財務・戦略的SWOT分析
    Summary Power Engineering Consulting Joint Stock Company 1 (PECC1), formerly Power Engineering Consulting Company 1, a subsidiary of Vietnam Electricity, is a power company that offers engineering consulting services. The company offers engineering advisory services such as construction, design, fea …
  • Cytodyn Inc (CYDY):企業の財務・戦略的SWOT分析
    Summary Cytodyn Inc (Cytodyn) is a clinical-stage biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment of Human Immunodeficiency Virus (HIV) infections. Its pipeline products include Leronlimab (PRO 140), a ful …
  • Zain Group (ZAIN):企業の財務・戦略的SWOT分析
    Zain Group (ZAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Lahey Hospital and Medical Center:企業の戦略的SWOT分析
    Lahey Hospital and Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • PeptiDream Inc (4587):企業の財務・戦略的SWOT分析
    Summary PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform that helps to produ …
  • Tecrea Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Tecrea Ltd (Tecrea) is a cell and tissue delivery technology for research and drug development applications. The company develops Nanocin reagents and ingredients support research and development in academic and industrial research labs. It develops Nanocin-plasmid and Nanocin-RNA kits that …
  • Altin Yunus Cesme Turistik Tesisler A.S.
    Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report Summary Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Echosens SA:医療機器:M&Aディール及び事業提携情報
    Summary Echosens SA (Echosens), a subsidiary of Inner Mongolia Free Han & Mongolia Pharmaceutical Co Ltd, is a medical device company that offers diagnostic products. The company designs and develops diagnosis solutions for patients with chronic liver diseases. It offers fibrometer, fibroscan, fibro …
  • Associated Alcohols & Breweries Limited.:企業の戦略・SWOT・財務情報
    Associated Alcohols & Breweries Limited. - Strategy, SWOT and Corporate Finance Report Summary Associated Alcohols & Breweries Limited. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆